Warath Chantaksinopas, K. Cattapan, Wiwatana Thanomkiat, Sarayut L Geater, Nantaka Kiranantawat
{"title":"恶性胸腔积液晚期肺癌患者手术相关肿瘤播散的相关因素","authors":"Warath Chantaksinopas, K. Cattapan, Wiwatana Thanomkiat, Sarayut L Geater, Nantaka Kiranantawat","doi":"10.31584/jhsmr.20241053","DOIUrl":null,"url":null,"abstract":"Objective: Pleural procedure-related tumor seeding detected by computed tomography (CT) is common in lung cancer patients with malignant pleural effusion. This study aimed to identify the incidence of tumor seeding and the associated factors among lung cancer patients with malignant pleural effusions. Material and Methods: This retrospective cohort study was conducted on 146 lung cancer patients with malignant pleural effusions, diagnosed between 2010 and 2017, who underwent at least 1 pleural procedure and had at least 2 series of CT images. The potential factors were categorized into clinical characteristics, pleural characteristics, treatment factors, and pleural procedures. Incidence rate ratios (IRR) were analyzed by Poisson regression to identify factors that were independently associated with tumor seeding. Results: The incidence of procedure-related tumor seeding was 26%. Significantly increased IRRs of tumor seeding were found in relation to 1 time (IRR 5.653, 95% confidence interval [CI] 2.549 to 12.538) and ≥2 times of conventional intercostal chest drainage (ICD) insertion (IRR 5.837, 95% CI 1.768 to 19.266), 1 time (IRR 8.924, 95% CI 3.181 to 25.033) and ≥2 times of pleural biopsy (IRR 6.485, 95% CI 1.372 to 30.660), adenocarcinoma (IRR 8.329, 95% CI 2.804 to 24.747), and pleural thickening (IRR 12.458, 95% CI 1.360 to 114.152). Conclusion: Patients who had at least one pleural biopsy or ICD insertion, pleural fluid cytology positive or suspicious for malignancy, adenocarcinoma, or pleural thickening were found to be significantly at risk for tumor seeding.","PeriodicalId":36211,"journal":{"name":"Journal of Health Science and Medical Research","volume":"63 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors Associated with Procedure-related Tumor Seeding in Advanced Stage Lung Cancer Patients with Malignant Pleural Effusions\",\"authors\":\"Warath Chantaksinopas, K. Cattapan, Wiwatana Thanomkiat, Sarayut L Geater, Nantaka Kiranantawat\",\"doi\":\"10.31584/jhsmr.20241053\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Pleural procedure-related tumor seeding detected by computed tomography (CT) is common in lung cancer patients with malignant pleural effusion. This study aimed to identify the incidence of tumor seeding and the associated factors among lung cancer patients with malignant pleural effusions. Material and Methods: This retrospective cohort study was conducted on 146 lung cancer patients with malignant pleural effusions, diagnosed between 2010 and 2017, who underwent at least 1 pleural procedure and had at least 2 series of CT images. The potential factors were categorized into clinical characteristics, pleural characteristics, treatment factors, and pleural procedures. Incidence rate ratios (IRR) were analyzed by Poisson regression to identify factors that were independently associated with tumor seeding. Results: The incidence of procedure-related tumor seeding was 26%. Significantly increased IRRs of tumor seeding were found in relation to 1 time (IRR 5.653, 95% confidence interval [CI] 2.549 to 12.538) and ≥2 times of conventional intercostal chest drainage (ICD) insertion (IRR 5.837, 95% CI 1.768 to 19.266), 1 time (IRR 8.924, 95% CI 3.181 to 25.033) and ≥2 times of pleural biopsy (IRR 6.485, 95% CI 1.372 to 30.660), adenocarcinoma (IRR 8.329, 95% CI 2.804 to 24.747), and pleural thickening (IRR 12.458, 95% CI 1.360 to 114.152). Conclusion: Patients who had at least one pleural biopsy or ICD insertion, pleural fluid cytology positive or suspicious for malignancy, adenocarcinoma, or pleural thickening were found to be significantly at risk for tumor seeding.\",\"PeriodicalId\":36211,\"journal\":{\"name\":\"Journal of Health Science and Medical Research\",\"volume\":\"63 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Health Science and Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31584/jhsmr.20241053\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Health Science and Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31584/jhsmr.20241053","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的:在恶性胸腔积液的肺癌患者中,通过计算机断层扫描(CT)发现与胸腔手术相关的肿瘤播种很常见。本研究旨在确定恶性胸腔积液肺癌患者中肿瘤播散的发生率及其相关因素。材料和方法:这项回顾性队列研究的对象是在 2010 年至 2017 年期间确诊的 146 例恶性胸腔积液肺癌患者,这些患者至少接受过一次胸膜手术,并至少有两组 CT 图像。潜在因素分为临床特征、胸腔特征、治疗因素和胸腔手术。通过泊松回归分析了发病率比(IRR),以确定与肿瘤播种独立相关的因素。结果与手术相关的肿瘤播种发生率为 26%。常规肋间胸腔引流 (ICD) 插入 1 次(IRR 为 5.653,95% 置信区间 [CI] 为 2.549 到 12.538)和≥2 次(IRR 为 5.837,95% 置信区间 [CI] 为 1.768 to 19.266)、胸膜活检 1 次(IRR 8.924,95% CI 3.181 to 25.033)和≥2 次(IRR 6.485,95% CI 1.372 to 30.660)、腺癌(IRR 8.329,95% CI 2.804 to 24.747)和胸膜增厚(IRR 12.458,95% CI 1.360 to 114.152)。结论至少进行过一次胸膜活检或植入 ICD、胸腔积液细胞学检查呈阳性或疑似恶性肿瘤、腺癌或胸膜增厚的患者有明显的肿瘤播种风险。
Factors Associated with Procedure-related Tumor Seeding in Advanced Stage Lung Cancer Patients with Malignant Pleural Effusions
Objective: Pleural procedure-related tumor seeding detected by computed tomography (CT) is common in lung cancer patients with malignant pleural effusion. This study aimed to identify the incidence of tumor seeding and the associated factors among lung cancer patients with malignant pleural effusions. Material and Methods: This retrospective cohort study was conducted on 146 lung cancer patients with malignant pleural effusions, diagnosed between 2010 and 2017, who underwent at least 1 pleural procedure and had at least 2 series of CT images. The potential factors were categorized into clinical characteristics, pleural characteristics, treatment factors, and pleural procedures. Incidence rate ratios (IRR) were analyzed by Poisson regression to identify factors that were independently associated with tumor seeding. Results: The incidence of procedure-related tumor seeding was 26%. Significantly increased IRRs of tumor seeding were found in relation to 1 time (IRR 5.653, 95% confidence interval [CI] 2.549 to 12.538) and ≥2 times of conventional intercostal chest drainage (ICD) insertion (IRR 5.837, 95% CI 1.768 to 19.266), 1 time (IRR 8.924, 95% CI 3.181 to 25.033) and ≥2 times of pleural biopsy (IRR 6.485, 95% CI 1.372 to 30.660), adenocarcinoma (IRR 8.329, 95% CI 2.804 to 24.747), and pleural thickening (IRR 12.458, 95% CI 1.360 to 114.152). Conclusion: Patients who had at least one pleural biopsy or ICD insertion, pleural fluid cytology positive or suspicious for malignancy, adenocarcinoma, or pleural thickening were found to be significantly at risk for tumor seeding.